Processa Pharmaceuticals, Inc. Cash Provided by (Used in) Financing Activities, Discontinued Operations
Processa Pharmaceuticals, Inc. (PCSA) reported Cash Provided by (Used in) Financing Activities, Discontinued Operations of -$14.36 thousand for the 6-month period ending 2015-06-30, per its 10-Q filed 2017-08-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations · last filed 2017-08-30
- 2015-06-30: Cash Provided by (Used in) Financing Activities, Discontinued Operations 6 month -$14.36K.
| Period end | Cash Provided by (Used in) Financing Activities, Discontinued Operations 6 month |
|---|---|
| 2015-06-30 | -$14.36K 10-Q · filed 2017-08-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |